IPCI
COM:INTELLIPHARMACEUTICS
Intellipharmaceutics International
- Stock
Last Close
0.09
05/03 15:01
Market Cap
2.65M
Beta: -
Volume Today
16.90K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Nov '14 | Nov '15 | Nov '16 | Nov '17 | Nov '18 | Nov '19 | Nov '20 | Nov '21 | Nov '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 57.83K - | 183.66K 217.57% | 300.39K 63.56% | 230.90K 23.13% | 56.34K 75.60% | |||||
average payables | 739.23K - | 1.85M 149.99% | 1.92M 3.77% | 1.43M 25.24% | 2.35M 64.04% | 3.20M 36.08% | 3.93M 22.82% | 3.94M 0.29% | 3.77M 4.30% | |
average receivables | 1.50M - | 1.14M 24.02% | 1.05M 8.03% | 1.24M 18.63% | 1.28M 3.40% | 1.10M 14.55% | 1.00M 8.64% | 658.35K 34.21% | 328.78K 50.06% | |
book value per share | 2.13 - | -0.06 102.72% | 0.42 821.70% | 0.12 70.20% | 0.86 591.45% | -0.17 119.86% | -0.27 56.61% | -0.28 3.41% | -0.32 15.34% | |
capex per share | -0.33 - | -0.18 45.71% | -0.19 6.58% | -0.59 204.61% | -0.02 96.39% | -0.00 96.84% | -0.00 75.48% | |||
capex to depreciation | -2.02 - | -1.14 43.49% | -1.34 17.44% | -3.50 161.70% | -0.17 95.28% | -0.03 82.70% | -0.01 67.34% | |||
capex to operating cash flow | 0.45 - | 0.11 74.62% | 0.08 27.60% | 0.30 262.49% | 0.01 97.29% | 0.00 73.15% | -0.03 1,691.33% | |||
capex to revenue | -0.09 - | -0.11 19.92% | -0.23 118.13% | -0.33 44.44% | -0.06 82.17% | -0.00 92.96% | -0.00 33.51% | |||
cash per share | 1.84 - | 0.74 59.80% | 1.55 110.19% | 0.61 60.59% | 1.39 128.01% | 0.00 99.79% | 0.01 186.36% | 0.03 205.88% | 0.00 90.35% | |
days of inventory on hand | 59.97 - | 735.59 1,126.61% | 3.85K 423.89% | |||||||
days payables outstanding | 30.40 - | 152.50 401.57% | 36.08 76.34% | 1.07K 2,860.23% | 7.73K 623.44% | 41.47K 436.69% | ||||
days sales outstanding | 55.61 - | 83.52 50.18% | 187.39 124.38% | 87.93 53.07% | 263.81 200.01% | 99.93 62.12% | 273.07 173.25% | 2.16K - | ||
debt to assets | 0.18 - | 0.30 62.63% | 0.19 36.38% | 0.17 7.84% | 0.16 10.56% | 0.50 221.51% | 0.62 24.34% | 0.91 46.63% | 1.62 77.59% | |
debt to equity | 0.29 - | -11.29 3,946.83% | 1.35 111.98% | 3.34 146.96% | 0.44 86.93% | -0.52 218.20% | -0.33 35.13% | -0.24 29.74% | -0.22 6.46% | |
dividend yield | ||||||||||
earnings yield | -0.06 - | -0.15 154.38% | -0.14 9.52% | -0.33 143.13% | -8.52 2,462.12% | -2.49 70.79% | -1.16 53.20% | -1.60 37.42% | -1.17 26.60% | |
enterprise value | 62.13M - | 49.02M 21.11% | 71.56M 46.00% | 26.04M 63.61% | -3.24M 112.43% | 5.09M 257.24% | 4.82M 5.24% | 4.36M 9.58% | 4.71M 7.88% | |
enterprise value over ebitda | -19.75 - | -7.28 63.14% | -7.56 3.87% | -3.37 55.44% | 0.25 107.46% | -0.70 377.05% | -2.74 293.16% | -1.11 59.25% | -1.78 59.58% | |
ev to operating cash flow | -36.23 - | -12.96 64.23% | -11.44 11.72% | -4.27 62.72% | 0.26 106.07% | -0.76 395.17% | 43.02 5,732.32% | -1.77 104.12% | -3.39 91.28% | |
ev to sales | 7.08 - | 11.97 69.00% | 31.85 165.99% | 4.73 85.15% | -1.89 139.95% | 1.46 177.38% | 3.44 135.32% | 71.58 - | ||
free cash flow per share | -1.08 - | -1.77 64.48% | -2.54 43.07% | -2.56 0.83% | -2.65 3.57% | -0.31 88.31% | 0.00 101.48% | -0.08 1,920.67% | -0.04 49.84% | |
free cash flow yield | -0.04 - | -0.09 123.73% | -0.09 6.61% | -0.30 226.10% | -7.81 2,525.17% | -2.05 73.70% | 0.04 101.81% | -0.77 2,159.68% | -0.56 26.35% | |
graham net net | 0.98 - | -1.22 224.06% | -0.69 43.33% | -1.31 89.09% | 0.07 105.20% | -0.30 544.81% | -0.37 21.31% | -0.32 14.18% | -0.35 11.50% | |
graham number | 8.95 - | 2.02 77.45% | 5.98 196.03% | 2.83 52.67% | 7.48 164.37% | 1.20 83.94% | 0.93 22.43% | 1.04 12.08% | 0.79 24.06% | |
income quality | 0.44 - | 0.51 14.37% | 0.62 21.24% | 0.69 11.79% | 0.91 32.00% | 0.82 9.42% | -0.03 104.01% | 0.48 1,546.96% | 0.48 0.33% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -10.41 - | -27.72 166.35% | -36.45 31.51% | -15.70 56.94% | -52.21 232.64% | -31.65 39.37% | -4.82 84.76% | -7.60 57.46% | -9.77 28.66% | |
interest debt per share | 0.77 - | 0.76 1.34% | 0.67 12.52% | 0.59 12.11% | 0.43 26.68% | 0.10 76.78% | 0.13 31.17% | 0.08 35.93% | 0.08 5.63% | |
inventory turnover | 6.09 - | 0.50 91.85% | 0.09 80.91% | |||||||
invested capital | 0.29 - | -11.29 3,946.83% | 1.35 111.98% | 3.34 146.96% | 0.44 86.93% | -0.52 218.20% | -0.33 35.13% | -0.24 29.74% | -0.22 6.46% | |
market cap | 64.92M - | 49.22M 24.19% | 74.20M 50.76% | 26.65M 64.08% | 1.61M 93.94% | 3.25M 101.33% | 2.91M 10.38% | 3.22M 10.41% | 2.46M 23.42% | |
net current asset value | 3.02M - | -2.44M 180.85% | -1.16M 52.49% | -3.45M 197.17% | 1.35M 139.06% | -5.97M 543.11% | -8.22M 37.82% | -9.15M 11.28% | -11.52M 25.87% | |
net debt to ebitda | 0.89 - | 0.03 96.64% | 0.28 834.22% | 0.08 71.81% | 0.38 379.69% | -0.25 166.83% | -1.08 330.83% | -0.29 72.98% | -0.85 189.56% | |
net income per share | -1.67 - | -3.13 87.02% | -3.80 21.43% | -2.86 24.83% | -2.89 1.08% | -0.37 87.02% | -0.14 61.58% | -0.17 21.48% | -0.09 50.01% | |
operating cash flow per share | -0.74 - | -1.59 113.89% | -2.34 47.22% | -1.97 15.97% | -2.63 33.42% | -0.31 88.24% | 0.00 101.54% | -0.08 1,857.74% | -0.04 49.84% | |
payables turnover | 12.01 - | 2.39 80.06% | 10.12 322.65% | 0.34 96.62% | 0.05 86.18% | 0.01 81.37% | ||||
receivables turnover | 6.56 - | 4.37 33.41% | 1.95 55.43% | 4.15 113.10% | 1.38 66.67% | 3.65 163.99% | 1.34 63.40% | 0.17 - | ||
research and ddevelopement to revenue | 1.68 - | 6.32 275.32% | 1.90 69.96% | 2.51 32.16% | 32.70 - | |||||
return on tangible assets | -0.49 - | -1.42 190.68% | -1.27 10.64% | -1.20 5.86% | -1.20 0.05% | -2.13 77.73% | -1.00 52.98% | -2.45 145.14% | -2.02 17.70% | |
revenue per share | 3.80 - | 1.72 54.73% | 0.84 51.14% | 1.77 110.89% | 0.36 79.74% | 0.16 55.15% | 0.06 63.12% | 0.00 - | ||
roe | -0.79 - | 54.01 6,975.76% | -9.09 116.82% | -22.92 152.27% | -3.35 85.38% | 2.19 165.34% | 0.54 75.47% | 0.63 17.47% | 0.27 56.65% | |
roic | -0.55 - | -4.94 799.51% | -3.74 24.32% | -4.97 33.04% | -2.26 54.56% | 4.38 293.81% | 1.17 73.33% | 0.65 43.98% | 0.35 46.03% | |
sales general and administrative to revenue | 1.58 - | |||||||||
shareholders equity per share | 2.13 - | -0.06 102.72% | 0.42 821.70% | 0.12 70.20% | 0.86 591.45% | -0.17 119.86% | -0.27 56.61% | -0.28 3.41% | -0.32 15.34% | |
stock based compensation to revenue | 0.20 - | 0.10 48.81% | 1.01 886.10% | 0.32 68.41% | 0.54 70.37% | 0.08 85.97% | 0.05 32.75% | -0.76 - | ||
tangible asset value | 4.91M - | -137.69K 102.80% | 1.12M 910.73% | 386.38K 65.39% | 4.10M 961.72% | -3.69M 190.00% | -6.31M 71.00% | -8.16M 29.17% | -10.58M 29.69% | |
tangible book value per share | 2.13 - | -0.06 102.72% | 0.42 821.70% | 0.12 70.20% | 0.86 591.45% | -0.17 119.86% | -0.27 56.61% | -0.28 3.41% | -0.32 15.34% | |
working capital | 3.06M - | -2.28M 174.32% | 1.50M 166.05% | -1.08M 172.13% | 3.41M 414.47% | -5.97M 275.01% | -8.22M 37.82% | -9.15M 11.28% | -11.52M 25.87% |
All numbers in CAD (except ratios and percentages)